scholarly journals Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

2004 ◽  
Vol 10 (10) ◽  
pp. 1248-1255 ◽  
Author(s):  
Mitchell L. Shiffman ◽  
R. Todd Stravitz ◽  
Melissa J. Contos ◽  
A. Scott Mills ◽  
Richard K. Sterling ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Living Donor ◽  
Deceased Donor ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Chronic Hepatitis C Virus

scholarly journals Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation

2006 ◽  
Vol 13 (1) ◽  
pp. 122-129 ◽  
Author(s):  
Norah A. Terrault ◽  
Mitchell L. Shiffman ◽  
Anna S.F. Lok ◽  
Sammy Saab ◽  
Lan Tong ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Living Donor ◽  
Deceased Donor ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Deceased Donor Liver Transplantation

Su1029 Plasma Cell Hepatitis Following Liver Transplantation in Patients With Chronic Hepatitis C Virus Infection

2015 ◽  
Vol 148 (4) ◽  
pp. S-1043
Author(s):  
Jung Hyun Kwon ◽  
Ibrahim A. Hanouneh ◽  
Daniela Allende ◽  
Lisa Yerian ◽  
teresa diago ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Chronic Hepatitis C ◽  
Plasma Cell ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus

scholarly journals Living-Donor Liver Transplantation and Hepatitis C

HPB Surgery ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-13 ◽  
Author(s):  
Nobuhisa Akamatsu ◽  
Yasuhiko Sugawara
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Antiviral Treatment ◽  
Sustained Viral Response ◽  
Deceased Donor ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Primary Indication

Hepatitis-C-virus- (HCV-) related end-stage cirrhosis is the primary indication for liver transplantation in many countries. Unfortunately, however, HCV is not eliminated by transplantation and graft reinfection is universal, resulting in fibrosis, cirrhosis, and finally graft decompression. In areas with low deceased-donor organ availability like Japan, living-donor liver transplantation (LDLT) is similarly indicated for HCV cirrhosis as deceased-donor liver transplantation (DDLT) in Western countries and accepted as an established treatment for HCV-cirrhosis, and the results are equivalent to those of DDLT. To prevent graft failure due to recurrent hepatitis C, antiviral treatment with pegylated-interferon and ribavirin is currently considered the most promising regimen with a sustained viral response rate of around 30% to 35%, although the survival benefit of this regimen remains to be investigated. In contrast to DDLT, many Japanese LDLT centers have reported modified treatment regimens as best efforts to secure first graft, such as aggressive preemptive antiviral treatment, escalation of dosages, and elongation of treatment duration.

Clinical Outcomes of Living Donor Liver Transplantation for Hepatitis C Virus (HCV)-Positive Patients

2006 ◽  
Vol 81 (3) ◽  
pp. 350-354 ◽  
Author(s):  
Yasutsugu Takada ◽  
Hironori Haga ◽  
Takashi Ito ◽  
Motoshige Nabeshima ◽  
Kohei Ogawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Outcomes ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation
Sign in / Sign up

Export Citation Format

Share Document